Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
80.01
-2.14 (-2.60%)
Mar 9, 2026, 3:00 PM CST
-6.97% (1Y)
| Market Cap | 21.18B |
| Revenue (ttm) | 812.73M |
| Net Income (ttm) | -160.70M |
| Shares Out | 264.71M |
| EPS (ttm) | -0.61 |
| PE Ratio | n/a |
| Forward PE | 90.75 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,025,804 |
| Average Volume | 3,133,992 |
| Open | 80.92 |
| Previous Close | 82.15 |
| Day's Range | 78.51 - 81.92 |
| 52-Week Range | 75.10 - 134.17 |
| Beta | 0.20 |
| RSI | 41.78 |
| Earnings Date | Mar 28, 2026 |